Unicycive Therapeutics To Implement 1-For-10 Reverse Split, Stock Down In Pre-Market

(RTTNews) - Unicycive Therapeutics, Inc. (UNCY), Tuesday announced the decision to implement a 1-for-10 reverse split of the issued shares of its common stock, effective June 18, 2025.

The move is intended to increase the bid price of the common stock to enable the company to regain compliance with the $1.00 minimum bid price requirement for continued listing on The Nasdaq Capital Market.

The company expects to begin trading on a split-adjusted basis when the market opens on June 20, 2025, and will continue to trade on The Nasdaq Capital Market under the symbol "UNCY."

In the pre-market hours, UNCY is moving down 14.35 percent, to $0.64 on the Nasdaq.